ACAA2 expression was significantly elevated (P = 5.9*10-6) in TD-NEPC tumours with a fold-change of 3 (Fig. 1a) relative to the control, non-SCNC LNCaP tumours in analysis of previously published proteomic profiling [26]. The gene discussed is ACAA2; the disease is neoplasm.